SIGLEC15 and neoplasm: CTLA4, HAVCR2, PVRL2, PDCD1, SIGLEC15, TIGIT, and VTCN1 expression levels were higher in tumor tissues, while CD244, LAG3, PDCD1LG2, and CD274 expression levels were found to be lower (Supplementary Figure S4C).